Next Article in Journal
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer
Previous Article in Journal
DNA Polymerase Alpha Subunit B Is a Binding Protein for Erlotinib Resistance in Non-Small Cell Lung Cancer
Previous Article in Special Issue
Stromal CCL2 Signaling Promotes Mammary Tumor Fibrosis through Recruitment of Myeloid-Lineage Cells
Open AccessArticle

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia

1
Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland
2
Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-080 Lublin, Poland
3
Department of Clinical Transplantology, Medical University of Lublin, 20-093 Lublin, Poland
4
Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland
*
Authors to whom correspondence should be addressed.
Cancers 2020, 12(9), 2614; https://doi.org/10.3390/cancers12092614
Received: 30 July 2020 / Revised: 29 August 2020 / Accepted: 10 September 2020 / Published: 14 September 2020
(This article belongs to the Special Issue Emerging Roles of Immune Cells in Cancer Development and Progression)
Chronic lymphocytic leukaemia (CLL) is a malignancy of mature B cells. Tumour microenvironment is important for survival and proliferation of malignant cells. In the current study, we investigated the potential role of circulating monocytic myeloid-derived suppressor cells (M-MDSC) in CLL. We have observed an increased percentage of M-MDSC cells in CLL patients. Moreover, we have observed a close association with unfavourable prognostic markers, which suggests a potential role of M-MDSC as a prognostic factor in CLL. We have established an association between a high M-MDSC percentage on the one side and shorter time-to-treatment and overall survival on the other. Therefore, we strongly suggest to use M-MDSC percentage as another prognostic factor.
In the current study, we analysed the role and prognostic value of myeloid-derived suppressor cells (MDSC) in chronic lymphocytic leukaemia (CLL). The frequency of circulating monocytic MDSC (M-MDSC; defined as CD14+CD11b+CD15-HLA-DR-/low cells) was assessed in correlation with clinical and laboratory parameters characterising the disease activity and patient immune status. Samples of peripheral blood from untreated CLL patients and healthy volunteers were stained with monoclonal antibodies for flow cytometry analysis. CLL patients with M-MDSC percentages above 9.35% (according to the receiver operating characteristic (ROC) analysis) had a shorter time-to-treatment and shorter survival time than the group with a lower percentage of M-MDSC. The M-MDSC percentage was higher in patients with adverse prognostic factors (i.e., 17p and 11q deletion and CD38 and ZAP-70 expression). A high M-MDSC percentage was linked to significantly lower expression of the CD3ζ in T cells. Furthermore, an analysis of immune regulatory molecules (arginase 1 (ARG1), nitric oxide synthase (NOS2), indoleamine 2,3-dioxygenase (IDO), transforming growth factor beta (TGF-β), and interleukin (IL)-10) was performed. By the means of flow cytometry and RT-qPCR, we showed an overexpression of three of them in M-MDSC of CLL patients. M-MDSC cells seem to be an important factor in the immunosuppressive microenvironment of CLL and seem to be a good and novel prognostic factor View Full-Text
Keywords: M-MDSC; CLL; ARG1; NOS2; IDO; TGF-β; IL-10; CD3ζ M-MDSC; CLL; ARG1; NOS2; IDO; TGF-β; IL-10; CD3ζ
Show Figures

Figure 1

MDPI and ACS Style

Zarobkiewicz, M.; Kowalska, W.; Chocholska, S.; Tomczak, W.; Szymańska, A.; Morawska, I.; Wojciechowska, A.; Bojarska-Junak, A. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia. Cancers 2020, 12, 2614. https://doi.org/10.3390/cancers12092614

AMA Style

Zarobkiewicz M, Kowalska W, Chocholska S, Tomczak W, Szymańska A, Morawska I, Wojciechowska A, Bojarska-Junak A. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia. Cancers. 2020; 12(9):2614. https://doi.org/10.3390/cancers12092614

Chicago/Turabian Style

Zarobkiewicz, Michał; Kowalska, Wioleta; Chocholska, Sylwia; Tomczak, Waldemar; Szymańska, Agata; Morawska, Izabela; Wojciechowska, Agnieszka; Bojarska-Junak, Agnieszka. 2020. "High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia" Cancers 12, no. 9: 2614. https://doi.org/10.3390/cancers12092614

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop